These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2692495)

  • 21. Managing hypertension in chronic renal disease.
    Faubert PF; Porush JG
    Geriatrics; 1987 Jan; 42(1):49-51, 55-8. PubMed ID: 2879773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antihypertensive therapy in renal failure].
    Mayer G
    Acta Med Austriaca; 1995; 22(3):51-3. PubMed ID: 8571752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should beta-blockers be used to control hypertension in people with chronic kidney disease?
    Hart PD; Bakris GL
    Semin Nephrol; 2007 Sep; 27(5):555-64. PubMed ID: 17868793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug prevention of acute renal insufficiency].
    Lameire N
    Nephrologie; 1998; 19(2):69-73. PubMed ID: 9592776
    [No Abstract]   [Full Text] [Related]  

  • 26. Calcium-channel blockers in experimental and human acute renal failure.
    Schrier RW; Burke TJ
    Adv Nephrol Necker Hosp; 1988; 17():287-99. PubMed ID: 3124543
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effect of verapamil on cardio- and hemodynamics in rats with various models of hypertension].
    Spasov AA; Gurbanov KG; Seredintseva NV; Paperno AA
    Eksp Klin Farmakol; 1997; 60(3):30-3. PubMed ID: 9324394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intracellular calcium and renal function].
    del Río Vázquez A
    Med Clin (Barc); 1985 Jun; 85(4):145-50. PubMed ID: 4033272
    [No Abstract]   [Full Text] [Related]  

  • 29. Learning experiences from UNC. Renal autoregulation, drugs, and acute renal failure.
    Blythe WB
    N C Med J; 1985 Jul; 46(7):413-4. PubMed ID: 2993929
    [No Abstract]   [Full Text] [Related]  

  • 30. Losartan in patients with renal insufficiency.
    de Zeeuw D; Gansevoort RT; de Jong PE
    Can J Cardiol; 1995 Aug; 11 Suppl F():41F-44F. PubMed ID: 7664217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of methyldopa on renal function in patients with renal insufficiency.
    Brodwall EK; Myhre E; Stenbaek O; Hansen T
    Acta Med Scand; 1972 Apr; 191(4):339-41. PubMed ID: 5032678
    [No Abstract]   [Full Text] [Related]  

  • 32. [Modes of intensive therapy for arterial hypertension in children with terminal chronic kidney failure].
    Sharipov AM
    Urologiia; 2002; (3):49-51. PubMed ID: 12180062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of antimicrobial agents in the course of renal insufficiency].
    Novi C
    Clin Ter; 1972 Aug; 62(3):273-86. PubMed ID: 5081154
    [No Abstract]   [Full Text] [Related]  

  • 34. Renal protective aspects of calcium antagonists. International Workshop. Florence, Italy, April 14-16, 1991. Proceedings.
    Kidney Int Suppl; 1992 May; 36():S1-118. PubMed ID: 1351956
    [No Abstract]   [Full Text] [Related]  

  • 35. Calcium antagonists in hypertension.
    Bühler FR; Kiowski W
    J Hypertens Suppl; 1987 Aug; 5(3):S3-10. PubMed ID: 3312526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium channel blockers and nephroprotection.
    Ungar A; Di Serio C; Lambertucci L; Monami M; Masotti G
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):31-9. PubMed ID: 16640171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No clinical evidence for protective effects of calcium-channel blockers against acute renal failure.
    Hull RW; Hasbargen JA
    N Engl J Med; 1985 Dec; 313(23):1477-8. PubMed ID: 4058554
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the effects of ACE inhibitors and calcium channel blockers on the progression of renal failure.
    Zucchelli P; Zuccalà A; Gaggi R
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():46-51. PubMed ID: 8643208
    [No Abstract]   [Full Text] [Related]  

  • 39. [ACE inhibitors and the kidney].
    Hörl WH
    Wien Med Wochenschr; 1996; 146(11):231-4; discussion 234-5. PubMed ID: 8928521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological basis for use of calcium antagonists in hypertension.
    Scriabine A; Kazda S
    Magnesium; 1989; 8(5-6):253-65. PubMed ID: 2693846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.